Investigational device. Limited by Federal (or United States) law to investigational use.
AI/ML Cancerous Tissue Recognition & Surgical Guidance
Emet Surgical was established by a cancer survivor to develop tools that improve surgery outcomes
Driven by my own experience with surgical complications and multiple reoperations, I founded Emet Surgical and developed the ESP system. Our mission is to empower surgeons with better tools to enhance patient outcomes and prevent others from facing the challenges I endured.
Bob Witkow, Cancer Survivor, Emet Surgical Founder & CEO
ESP - Enhanced Surgical Precision
Our breakthrough system for minimally invasive surgery acts as a surgical co-pilot, analyzing live video feeds and overlaying vital information directly on the surgeon's monitor. Like modern driver assistance systems, ESP guides surgeons with real-time visual cues through intricate dissections and helps identify cancerous tissue.
Real-Time Dynamic Guidance
Through its analysis of the video feed, ESP processes the video images and overlays valuable information a map with anatomical features highlighted as an overlay on the surgeons video display. This feature will be especially helpful for surgeons seeking to establish the Critical View of Safety.
Cancerous Tissue Recognition
Based on IP licensed from the University of Minnesota, in real-time, ESP’s cancerous tissue recognition engine processes the video stream for anomalies suggestive of cancer. When it finds something suspicious it lets the surgeon know.
Commonly, the first thing a pathologist will do when a specimen comes into the lab is to conduct a “Gross Exam.” Surgeons on our advisory board call this approach “Gross Exam in the OR”.
Easy to Use With No New Training
Surgeons Emet Surgical interviewed shared they have little time for training and no desire to take time from their practices to learn how to use new instruments. They told us that broad adoption will require the ESP system to be easy-to-use with no new tools and training.
